← Back to Clinical Trials
Recruiting NCT05428137

Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals

Trial Parameters

Condition Obesity
Sponsor The Archer-Daniels-Midland Company
Study Type INTERVENTIONAL
Phase N/A
Enrollment 180
Sex ALL
Min Age 19 Years
Max Age 75 Years
Start Date 2022-07-01
Completion 2024-12
Interventions
ProbioticPostbioticPlacebo

Brief Summary

Investigate the effect of a probiotic (live bacteria) and postbiotic (heat-treated bacteria) strains in overweight individuals.

Eligibility Criteria

Inclusion Criteria: * Body mass index 25-33kg/m2 * Abdominal obesity (female waist circumference\>85cm; male waist circumference\>90cm) * written informed consent Exclusion Criteria: * Taking the following medication within 1 month before starting the study: appetite stimulants/suppressants, lipid lowering drug, contraceptive * taking antibiotics within 2 months before starting the study * secondary obesity or secondary hypertension, diabetes type 1, GI disease, dyslipidaemia, type 2diabetes, hypertension * consumption of pre- and probiotic-enriched products or dietary supplement for at least 4 weeks prior to the first screening visit * nicotine, drug or alcohol abuse, * other condition that, in the opinion of the investigators, would make participation not in the best interest of the patient or could prevent, limit or confound the Study's results

Related Trials